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PCardiac Effects of Sleep Apnea
Triggering of Nocturnal Arrhythmias
by Sleep-Disordered Breathing Events
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Objectives This study sought to evaluate respiratory disturbances as potential triggers for arrhythmia in patients with sleep-
disordered breathing (SDB).
Background SDB is associated with an increased risk of atrial fibrillation and nonsustained ventricular tachycardia (NSVT) as
well as a predilection for sudden cardiac death during nocturnal sleeping hours. However, prior research has not
established whether respiratory disturbances operate as triggers for nocturnal arrhythmias.
Methods Overnight polysomnograms from the Sleep Heart Health Study (n  2,816) were screened for paroxysmal atrial fibril-
lation and NSVT. We used the case-crossover design to determine whether apneas and/or hypopneas are temporally
associated with episodes of paroxysmal atrial fibrillation or NSVT. For each arrhythmia, 3 periods of sinus rhythm
were identified as control intervals. Polysomnograms were examined for the presence of respiratory disturbances,
oxygen desaturations, and cortical arousals within a 90-s hazard period preceding each arrhythmia or control period.
Results Fifty-seven participants with a wide range of SDB contributed 62 arrhythmias (76% NSVT). The odds of an ar-
rhythmia after a respiratory disturbance were nearly 18 times (odds ratio: 17.5; 95% confidence interval: 5.3 to
58.4) the odds of an arrhythmia occurring after normal breathing. The absolute rate of arrhythmia associated
with respiratory disturbances was low (1 excess arrhythmia per 40,000 respiratory disturbances). Neither hyp-
oxia nor electroencephalogram-defined arousals alone increased arrhythmia risk.
Conclusions Although the absolute arrhythmia rate is low, the relative risk of paroxysmal atrial fibrillation and NSVT during
sleep is markedly increased shortly after a respiratory disturbance. These results support a direct temporal link
between SDB events and the development of these arrhythmias. (J Am Coll Cardiol 2009;54:1797–804)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.06.038t
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wleep-disordered breathing (SDB) affects at least 5% of the
dult population (1) and is associated with hypertension (2),
ardiovascular disease (3), and mortality (3,4). Over the past
decades, relationships between SDB and cardiac arrhyth-
ias have been explored (5–10). Sleep-disordered breathing
ncreases the risk of incident atrial fibrillation (11) and the
isk of ventricular arrhythmias (12,13), which may relate to
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echanisms to explain these relationships include the poten-
ially pro-arrhythmic contributions of apnea-induced hypoxia
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system activity, both acutely and in
a tonic fashion (12,15–17). How-
ever, a causal link between SDB
and arrhythmia has not yet been
established. Confirming a tempo-
ral relationship between SDB
events and specific arrhythmia ep-
isodes could support causality and
would have important implications
for establishing therapeutic end
points and refining cardiovascular
risk stratification, as well as for
elucidating the pathophysiology of
arrhythmogenesis in SDB.
Recent data from SHHS (Sleep
Heart Health Study) demon-
strated a higher prevalence of atrial
fibrillation (AF) and nonsustained
ventricular tachycardia (NSVT) in
patients with severe SDB (apnea-
hypopnea index [AHI] 30
events/h) relative to patients with
low levels of SDB (AHI 5
events/h); these effects persisted
after adjusting for self-reported
oronary heart disease (CHD) and CHD risk factors (10).
owever, this comparison of extremes of SDB did not address
hether intermediate levels of SDB were also associated with
rrhythmias, and inferences were limited by the cross-sectional
esign. Using the case-crossover design, an analytic approach
eveloped to study the effects of transient exposures on the risk
f acute events (18,19), we now aim to extend prior research by
nvestigating, across the full range of SDB, whether respiratory
isturbances can trigger AF or NSVT.
ethods
tudy population. All data were ascertained from the
HHS, a multicenter longitudinal study designed to inves-
igate the cardiovascular consequences of SDB (20,21). Of
he 3,295 polysomnograms (PSGs) performed as part of the
econd SHHS examination, 2,816 records underwent de-
ailed review of the electrocardiography channel with the
im of identifying studies with at least 1 episode of
aroxysmal AF (PAF) or NSVT occurring during the sleep
eriod. This sample consisted of all records with an AHI
30 events/h that were technically satisfactory (n  2,569)
nd a sample of technically satisfactory studies (n  247)
ith an AHI 30 events/h from subjects with body mass
ndex between 18 and 40 kg/m2 not on continuous positive
irway pressure therapy who had been included in a prior
tudy comparing arrhythmias across extreme levels of SDB
10). This approach identified 57 participants with PAF or
Abbreviations
and Acronyms
AHI  apnea-hypopnea
index
CHD  coronary heart
disease
CI  confidence interval
EEG 
electroencephalogram
NREM  non–rapid eye
movement
NSVT  nonsustained
ventricular tachycardia
OR  odds ratio
PAF  paroxysmal atrial
fibrillation
PSG  polysomnogram
REM  rapid eye
movement
SCD  sudden cardiac
death
SDB  sleep-disordered
breathing
TST  total sleep timeSVT. sohort and PSG measurements. Standardized question-
aires from the second SHHS examination conducted
etween 2001 and 2002 were used to collect demograph-
c/anthropomorphic data (age, sex, race/ethnicity, height,
eight), self-reported cardiovascular risk-factors/disease
hypertension, diabetes mellitus, smoking status, heart
ailure, history of CHD [defined as prior myocardial
nfarction or percutaneous/surgical revascularization],
nd arrhythmia-related data [use of antiarrhythmic drugs,
rior pacemaker implantation]). The PSGs were performed
nd scored as described previously (10,21). The PSG
ummary data included total sleep time, AHI (the average
umber of apneas plus hypopneas per hour of sleep), sleep
tage distributions, arousal index, average oxygen saturation
uring sleep, and percentage of sleep time spent at 90%
xygen saturation.
tudy design. To investigate whether respiratory distur-
ances can trigger arrhythmic events, the case-crossover
tudy design was applied (18,19). This method analyzes the
isk of an event occurring in the context of a transient
xposure, with subjects serving as their own controls. For
ach case that is identified, a hazard period, during which
ubjects are presumed to be at increased risk for events, is
xamined for the presence of the exposure of interest.
orrespondingly, referent (control) periods are also exam-
ned for the exposure of interest. Subjects serve as their own
ontrols during periods when they are not having an event,
nd thus the association between the exposure and the event
s not confounded by subject characteristics that remain
ssentially constant during the observation period (e.g., age,
ex, body mass index, size of cardiac chambers). In the
urrent study, the “events” are arrhythmias (PAF and
SVT), the “exposures” are respiratory disturbances (apneas
r hypopneas), and the “referent” periods are derived from
ime spent in sinus rhythm (Fig. 1).
We defined the hazard period as 90 s, which incorporates
stimates of average respiratory disturbance duration (25 to
0 s), lag time between event cessation and nadir oxygen
aturation (15 to 30 s), the delay between nadir oxygen
aturation and resolution of hypoxia (10 to 15 s), and a
hort time after resolution of hypoxia during which its
hysiologic effects are still measurable (10 s). This se-
uence of events, as well as the duration of its components,
s derived from SHHS data and from prior physiologic and
linical studies (15–17,22–26).
To identify referent periods for each arrhythmia, we
elected randomly 3 epochs of sinus rhythm from the same
ubject that met the following criteria: 1) equal in duration
o the hazard period (90 s); 2) same sleep stage (1, 2, 3 to 4,
apid eye movement [REM]) as the corresponding arrhyth-
ic event; 3) 25% ectopic beats; and 4) absence of
omplex ventricular ectopy (bigeminy, trigeminy, quadra-
eminy, couplets (as defined in Mehra et al. [10]) and
auses 2 s. The strategy of matching on sleep stage was
sed to avoid confounding from state-dependent influences
uch as REM-related sympathetic nervous system surges.
T
t
r
4
B
o
t
s
A
w
a
c
C
b
i
t
s
d
E
e
m
c
a
c
a
Q
i
r
m
o
m
[
a
2
c
a
c
E
r
c

t
f
d
d
s
m
d
t
a
r
b
s
h
d
p
9
s
W
d
r
n
3
4
1
(
w
h
A
f
c
c
d
t
a
1799JACC Vol. 54, No. 19, 2009 Monahan et al.
November 3, 2009:1797–804 Triggering of Arrhythmias by Sleep-Disordered Breathingo minimize the effects of autocorrelation of exposure and
he “carryover effect” (27), the referent periods were further
estricted to those occurring at least 6 min (the duration of
hazard periods) before the onset of the arrhythmic event.
ecause it is unknown whether arrhythmias can affect the
ccurrence of respiratory disturbances, we used a unidirec-
ional design; the hazard period and all referent periods were
elected so that they occur before the arrhythmia of interest.
rrhythmia identification. Electrocardiographic data
ere obtained from a single bipolar lead (lead I) sampled
t 250 Hz collected as part of the overnight PSG. This
hannel was reviewed manually for arrhythmias using the
ompuMedics EDF Studio viewer (CompuMedics, Ab-
otsford, Victoria, Australia). The channels that provide
nformation on respiratory disturbances were disabled so
hat arrhythmias were identified without knowledge of
urrounding respiratory status; these channels were also
isabled during the referent period selection process.
pisodes of NSVT, defined as 3 consecutive ventricular
ctopic beats with an average heart rate of 100 beats/
in, and PAF, defined as a period of irregular, narrow
omplex rhythm without evidence of organized atrial
ctivity, were identified. Other recorded parameters in-
luded the absolute time of arrhythmia onset, duration of
rrhythmia (the interval between its onset and the first
RS complex that appeared to be a normally conducted
mpulse originating at the sinus node), and the concur-
ent sleep stage. Most participants had a single arrhyth-
ic event. However, 7 subjects had multiple arrhythmias
ver the course of their study. In these cases, 1 arrhyth-
ia from each sleep state (non-rapid eye movement
NREM] or REM) was chosen at random and treated as
n independent event in the analysis. Of these 7 subjects,
had all of their arrhythmias in NREM and thus
ontributed 1 event each, and 5 subjects had at least 1
rrhythmia in NREM and REM and therefore each
ontributed 2 events to the final dataset.
xposure assessment. The primary exposure was a respi-
Figure 1 Design of Case-Crossover Analysis
The 90-s hazard period immediately preceding an arrhythmia is evaluated for resp
precede the index arrhythmia by at least 6 min, are also examined for respiratory
period, that period is considered “exposed.”atory disturbance (apnea or hypopnea) defined solely by bhanges in amplitude of the airflow and effort signals for
10 s, as described previously (20,21). For each arrhythmia,
he associated hazard and referent periods were examined
or respiratory disturbances. For each of those respiratory
isturbances, the following characteristics were recorded:
uration of the apnea or hypopnea, attendant nadir oxygen
aturation (occurring within 25 s of the disturbance’s ter-
ination), whether an electroencephalogram (EEG)-
efined arousal occurred within 3 s of the disturbance’s
ermination, and the interval between the onset of an
ssociated arrhythmia (if present) and the termination of the
espiratory disturbance. If any part of a respiratory distur-
ance occurred during a hazard or referent period, the
ubject was considered “exposed” during that period. For
azard and referent periods during which no respiratory
isturbance occurred, the nadir oxygen saturation and the
resence or absence of an EEG-defined arousal over the
0-s window were also recorded.
Secondary exposures included EEG-defined arousals and
everal definitions of hypoxia based on nadir oxygen saturation.
e also created a 4-level variable to evaluate exposure to
ifferent levels of respiratory disturbance severity: 1) no respi-
atory disturbance (reference); 2) respiratory disturbances with
either an arousal nor hypoxia (defined as nadir SpO292%);
) respiratory disturbances linked to a nadir SpO2 92%; and
) respiratory disturbance linked to an EEG-defined arousal.
For quality control purposes, a randomly chosen subset (n
0) of PSGs was examined independently by 2 investigators
K.M. and R.M.). For this subset, no interobserver differences
ere noted in arrhythmia detection or exposure classification of
azard/referent periods.
bsolute arrhythmia rate assessment. To provide context
or the relative risk estimates derived from the case-
rossover results, a crude absolute rate of arrhythmia asso-
iated with respiratory disturbances was estimated using
ata from the SHHS cohort. The rate of arrhythmia during
he hazard period (Rh) was defined as the number of
rrhythmias occurring during the hazard period (Ah) divided
disturbances. Three randomly chosen referent periods of sinus rhythm, which
ances. If any part of a respiratory disturbance occurs during a hazard or referentiratory
disturby the total exposure time (Te):
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Ah
Te
he total exposure time (Te) was calculated as the product of
he total number of respiratory disturbances experienced by
he entire cohort and the exposure time per respiratory
isturbance (h):
Te  
i1
N
AHIi  TSTi  h
here h is defined as the 90-s hazard period, N is the total
umber of participants in the cohort, and AHIi and TSTi are
he apnea-hypopnea index and the total sleep time, respec-
ively, of a given participant. The rate of arrhythmia outside
he hazard period (Ro) was defined as the number of
rrhythmias occurring during nonexposed periods (Ao) di-
ided by the total unexposed time (Tu):
Ro 
Ao
Tu
he total unexposed time (Tu) was computed by subtracting
he total exposed time (Te) from the aggregate TST of the
ntire cohort:
Tu  
i1
N
TSTi  Te
he absolute rate difference was taken as the difference
etween the rate of arrhythmia within the exposure period
nd the rate of arrhythmia outside of the exposure period
Rh  Ro). To make this absolute rate difference estimate
ore readily interpretable, we used the exposure period
uration to convert the rate difference (excess arrhythmias
er unit of sleep duration) to the number of respiratory
isturbances associated with 1 excess arrhythmia (analogous
o the “number needed to treat”). It should be noted that,
nlike the matched odds ratio (OR) from the case-crossover
esign, this estimate has no inherent matching and there-
ore does not control for any confounding variables (demo-
raphics, medical history, and sleep characteristics).
tatistical analysis. Univariate descriptive statistics were
sed to summarize subject characteristics. Bivariate compar-
sons of characteristics for participants with and without
rrhythmia were evaluated using the Pearson chi-square test
or categorical data, the 2-sample t test for normally
istributed measures, and the Wilcoxon rank-sum test for
kewed measures. All subsequent analyses were restricted to
he participants with arrhythmia. Descriptive analyses were
tratified by type of arrhythmia (PAF or NSVT) and by
eriod type (hazard or referent). To estimate the odds of an
rrhythmia occurring during the hazard period after a
espiratory disturbance relative to the odds of an arrhythmia
ccurring during normal nocturnal breathing, the Mantel-
aenszel matched OR and conditional logistic regression, atratified on the arrhythmia event, were used. For the 5
ubjects who contributed 2 arrhythmias, each arrhythmia
as treated as coming from an independent subject. The
ain analyses were repeated stratified on the individual and
ielded similar results. Exploratory analyses were stratified
y the type of arrhythmia (PAF or NSVT) and by sleep
tate (NREM vs. REM). We also examined the 2-way
nteraction between sleep state and the exposure to deter-
ine whether the OR for an arrhythmia varied by NREM/
EM sleep state. Results are summarized using ORs and
5% confidence intervals (CIs); 2-sided p values are re-
orted. Analyses were conducted using SAS version 9.1
SAS Institute, Cary, North Carolina).
esults
ohort and sleep study characteristics. Demographic
haracteristics, relevant aspects of medical history, and
elected PSG features of the cohort, stratified by arrhythmia
tatus, are shown in Table 1. The sample that demonstrated
rrhythmias of interest (n  57) was elderly (72.1  10.1
ears of age), predominantly Caucasian (77%), and just over
ne-half (56%) were male. Risk factors for heart disease
ere prevalent: nearly one-half (49%) had hypertension,
9% were obese, and 44% were active or former smokers.
ighteen percent of those with arrhythmia reported a
istory of CHD and 2 subjects reported a history of heart
ailure. Medication data were available for 52 participants;
f these, 2 reported taking anti-arrhythmic drugs (1 each for
lass IB and class III), and 8 reported using beta-blockers.
he TST by PSG was approximately 6 h, with just under
0% of that time spent in REM sleep (19.0  6.3%). The
edian AHI was 13.6 events/h (interquartile range 6.2 to
5.5 events/h). Participants with arrhythmia were older, had a
igher proportion of sleep time with SpO2 90%, and had
lightly higher AHI compared with subjects who did not have
rrhythmia. In addition, the arrhythmia group had an in-
reased prevalence of hypertension, coronary heart disease, and
igh AHI (AHI 30 events/h) compared with the group
ithout arrhythmia.
rrhythmia characteristics. Features of the 62 detected
rrhythmias are shown in Table 2. The majority of reported
rrhythmias were NSVT (76%) and approximately two-
hirds (68%) of arrhythmias occurred in NREM sleep.
edian arrhythmia duration was 7 s for PAF and 3 s for
SVT. The longest episode of PAF lasted nearly 5 min.
he next longest episode was considerably shorter, at 12 s.
he longest episode of VT lasted 35 s, with the next longest
pisode lasting 19 s.
espiratory disturbance characteristics. A respiratory
isturbance occurred in 44 of the 62 hazard periods (71%)
nd in 65 of the 186 referent periods (35%). The overall
haracteristics of respiratory events in the hazard and
eferent periods were similar; in both periods, the majority
77%) of respiratory events was hypopneas. Only 1 central
pnea was identified, and it occurred in a referent period. Of
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November 3, 2009:1797–804 Triggering of Arrhythmias by Sleep-Disordered Breathinghe 44 respiratory events occurring in hazard periods, 18
41%) occurred in REM sleep. Of the 65 respiratory events
ccurring in referent periods, 39 (60%) occurred in REM
leep. Respiratory disturbance duration, associated nadir
xygen saturation, and the proportion with EEG-defined
rousals were similar for respiratory disturbances occurring
n hazard and referent periods (data not shown).
Sample Characteristics*Table 1 Sample Characteristics*
Characteristic
E
(
Demographics
Age, yrs† 6
Female 1,5
Caucasian 2,1
African-American 1
Other ethnicity 5
BMI, kg/m2
Overall 2
Obese (30 kg/m2) 1,0
Self-reported cardiovascular risk factors/disease
Hypertension‡ 9
Diabetes mellitus 2
Current or former smoker 1,3
Coronary heart disease‡ 2
Heart failure
Arrhythmia therapy§
Beta-blocker 2
Antiarrhythmic drug
Permanent pacemaker
Polysomnography data
TST, min
REM, % 2
Average SpO2 during sleep, % 9
SpO2 90%, % TST‡ 0
Overall AHI, events/h‡ 10
Low: AHI 5 6
Intermediate: AHI 5–29 1,9
High: AHI 30‡ 2
Arousal index (events/h) 15
Counts and percentages are shown for categorical variables, mean 
percentiles) are shown for non-normally distributed variables. *All
examination, other than for 5 participants from 1 site for which only da
between arrhythmia and nonarrhythmia groups. ‡p  0.05 for comp
available for 5 participants from 1 site).
AHI apnea-hypopnea index; BMI body mass index; NSVT nons
rapid eye movement sleep; SpO2  oxygen saturation; TST  total sle
rrhythmia CharacteristicsTable 2 Arrhythmia Characteristics
Total PAF NSVT
Events 62 15 47
Duration distribution, s 4 (2–7) 7 (3–9) 3 (2–5)
Sleep stage
NREM 42 (68%) 12 (80%) 30 (64%)
REM 20 (32%) 3 (20%) 17 (36%)
ounts and percentages are shown for categorical variables. Data are median (25th to 75th
ercentile) for non-normally distributed variables.
NREM  non-rapid eye movement sleep; other abbreviations as in Table 1. Base-crossover analysis. Table 3 shows the distribution of
atched sets (1 hazard period and 3 control periods)
ccording to the presence of a respiratory disturbance. Of
he 62 sets, 27 sets were concordant on the exposure. Of
hose 27 concordant sets, 15 sets did not have a respiratory
isturbance during the hazard period and, likewise, did not
ave a respiratory disturbance during any of the referent
ample
,816)
No Arrhythmia
(n  2,759)
PAF or NSVT
(n  57)
10.0 67.9 10.0 72.1 10.1
%) 1,534 (56%) 25 (44%)
%) 2,082 (76%) 44 (77%)
) 179 (6%) 5 (9%)
%) 498 (18%) 8 (14%)
5.2 29.2 5.2 29.1 4.9
%) 1,037 (38%) 22 (39%)
%) 908 (33%) 28 (49%)
%) 268 (10%) 7 (12%)
%) 1,374 (50%) 25 (44%)
) 217 (8%) 10 (18%)
) 38 (1%) 2 (4%)
%) 286 (10%) 8 (15%)
) 44 (2%) 2 (4%)
) 17 (1%) 1 (2%)
70 373 70 364 76
6.8 20.5 6.8 19.0 6.3
1.8 94.1 1.8 93.9 2.1
–2.9) 0.6 (0.1–2.9) 1.1 (0.2–6.2)
–19.0) 10.7 (5.6–18.9) 13.6 (6.2–25.5)
%) 595 (21%) 10 (18%)
%) 1,928 (70%) 36 (63%)
) 236 (9%) 11 (19%)
.2–21.7) 15.7 (11.3–21.5) 18.3 (11.0–24.0)
shown for normally distributed measures, and median (25th to 75th
te data were obtained from the second Sleep Heart Health Study
the baseline examination were available. †p  0.01 for comparison
between arrhythmia and nonarrhythmia groups. §n  52 (data not
d ventricular tachycardia; PAF paroxysmal atrial fibrillation; REM
e.
xposure to Respiratory Disturbance Duringazard Period and 3 Matched Refer nt Periodsn  62 Matched Sets)*
Table 3
Exposure to Respiratory isturbance During
Hazard Period and 3 Matched Referent Periods
(n  62 Matched Sets)*
Number of Referent Periods With
Respiratory Disturbance
Respiratory Disturbance
During Hazard Period?
Yes No
0 periods with respiratory disturbance 12 15
1 period with respiratory disturbance 15 2
2 periods with respiratory disturbance 5 1
3 periods with respiratory disturbance 12 0ntire S
n  2
8.0
59 (55
26 (76
84 (6%
06 (18
9.2
59 (38
36 (33
75 (10
99 (50
27 (8%
40 (1%
94 (10
46 (2%
18 (1%
373
0.5
4.1
.6 (0.1
.8 (5.6
05 (21
64 (70
47 (9%
.7 (11
SD are
covaria
ta from
arisonold entries indicate discordant sets; other entries are concordant sets.
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Triggering of Arrhythmias by Sleep-Disordered Breathing November 3, 2009:1797–804eriods; 12 sets had a respiratory disturbance during the
azard period and also had respiratory disturbances during
ll 3 referent periods. The remaining 35 sets showed various
evels of discordance on the exposure; for example, 5 sets
ad a respiratory disturbance during the hazard period, but
nly during 2 of the 3 referent periods. The odds of a
octurnal arrhythmia occurring within the 90-s hazard
eriod after a respiratory disturbance was 17-fold greater
han the odds of an arrhythmia occurring during normal
octurnal breathing (Mantel-Haenszel matched OR: 17.8;
5% CI: 5.0 to 63.0).
The conditional logistic regression results are shown in
able 4 for the primary analysis and several exploratory
nalyses. The OR computed using conditional logistic
egression was similar to the Mantel-Haenszel OR (17.5;
5% CI: 5.3 to 58.4). The results of the secondary analyses
tratified by the subject, rather than by the arrhythmia
vent, were consistent with the primary finding. Analyses
tratified by type of arrhythmia showed that the magnitude
f the association for PAF and NSVT was similar to that for
he overall group. An association remained for arrhythmias
ccurring during NREM sleep (OR: 14.2; 95% CI: 4.2 to
8.0), but could not be estimated for REM events because
f the small number of discordant sets. However, there was
o statistical evidence of an interaction between sleep stage
nd respiratory disturbance (p  0.99).
Exploratory analyses examined the association between
rrhythmias and secondary exposures. Significant associa-
ions between arrhythmias and respiratory disturbances were
een regardless of whether respiratory disturbances were
ssociated with nadir SpO2 92% or arousal (Table 4). In
ontrast, when the exposure was defined as hypoxia or
EG-defined arousal regardless of the presence of a respi-
atory disturbance, the associations were weak, inconsistent,
nd not statistically significant (data not shown).
isk of Arrhythmia After Respiratory Disturbanceompared With Risk of Arrhythmia During Normalcturnal Breathing
Table 4
Risk of Arrhythmia After Respiratory Disturbance
Compared With Risk of Arrhythmia During Normal
Nocturnal Breathing
Arrhythmias
Included in
Each Analysis
Odds Ratio
(95% CI)
Primary overall analysis 62 17.5 (5.3–58.4)
Subanalysis by arrhythmia type
PAF 15 17.9 (2.2–144.2)
NSVT 47 17.4 (4.0–75.7)
Subanalysis by sleep stage
NREM 42 14.2 (4.2–48.0)
REM 20 *
Subanalysis by respiratory disturbance
subtype
No respiratory disturbance 18 Reference
Respiratory disturbance without hypoxia
(nadir SpO2 92%) or arousal
14 24.1 (5.4–106.6)
Respiratory disturbance with hypoxia 20 13.6 (3.7–50.6)
Respiratory disturbance with arousal 10 21.8 (4.5–106.3)a
Unable to be calculated.
CI  confidence interval; other abbreviations as in Tables 1 and 2.bsolute arrhythmia rate estimation. For the entire co-
ort of 2,816 participants, the rate of arrhythmia during
xposed periods was 3.9/1,000 h sleep. The rate of arrhyth-
ia during unexposed periods was 2.9/1,000 h sleep. There-
ore, the absolute rate of arrhythmia associated with respi-
atory disturbances was estimated to be 1 excess arrhythmia
er 1,000 h of sleep (with a median AHI of 23 events/h) or
excess arrhythmia per 40,000 respiratory disturbances.
hus, a person with moderate SDB (AHI of 30 events/h)
ho sleeps an average of 8 h per night would be estimated
o have 1 excess arrhythmia every 5.6 months, or 2 per year.
iscussion
he main finding of the present study is the nearly 18-fold
ncrease in the relative risk of nocturnal arrhythmia within
0 s (a physiologically defined interval) after a respiratory
isturbance in patients with a broad range of SDB severity.
rior clinical and epidemiologic studies have established an
ssociation between SDB and arrhythmia (5–7,10,12,13),
ut the temporal relationship between the two, particularly
nvolving PAF and NSVT, has not previously been charac-
erized. A small study in patients with central sleep apnea
nd heart failure demonstrated suppression of PVCs in the
ubset that responded to continuous positive airway pressure
herapy (28), suggesting indirectly a link between central
pneas and ventricular ectopy. A small study of patients
ith severely depressed left ventricular systolic function,
evere SDB, and previously demonstrated ventricular ectopy
n Holter monitoring demonstrated that PVCs occurred
ore frequently in the apneic phase of obstructive apneas
han during other phases of the respiratory cycle (29).
nother study showed a higher frequency of apnea-
ssociated compared with non–apnea-associated arrhyth-
ias in 8 patients with SDB, left ventricular dysfunction,
nd prior implantable cardioverter-defibrillator device
lacement (13). However, none of these studies quantified
he extent to which sleep-related respiratory disturbances
perated as triggers for arrhythmias, and none investigated
AF as an arrhythmia of interest.
A prior study from the SHHS reported an increased odds
f arrhythmias among subjects with severe SDB (AHI 30
vents/h) compared with subjects who had an AHI of 5
vents/h (10). However, that analysis did not address the
ropensity for arrhythmias in subjects with more moderate
evels of SDB, as is found more frequently in the general
opulation. The current report analyzed all records of
articipants with an AHI 30 events/h. The majority of
dentified arrhythmias occurred among those with only
oderate levels of SDB (AHI 5 to 30 events/h). As shown
y the moderate median AHI of our cohort and the finding
hat most of the respiratory disturbances preceding arrhyth-
ias were hypopneas (as opposed to apneas), neither the
everity of SDB nor the severity of individual respiratory
isturbances needs to be extreme to increase the risk of
rrhythmia.
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November 3, 2009:1797–804 Triggering of Arrhythmias by Sleep-Disordered BreathingIn this study, we attempted to identify the relative
ontributions of hypoxia and arousal to arrhythmogenesis.
e identified all respiratory disturbances solely on the basis
f changes in airflow and effort signal amplitude, without
equiring a linked desaturation or arousal. We then second-
rily assessed whether the extent of linked desaturation or
rousal was related to propensity for PAF or NSVT. In
hese analyses, the ORs for arrhythmia did not vary accord-
ng to whether nadir saturation levels fell below 92% nor did
hey vary according to whether respiratory disturbances were
ssociated with a cortical arousal. However, since more than
ne-half of the respiratory disturbances in the hazard/
eferent periods were associated with a desaturation of3%
a commonly used clinical criterion) and the mean desatu-
ation for all respiratory disturbances that occurred in
azard/referent periods was 4%, it is possible that some
egree of hypoxic stress was contributory to the observed
ssociations. The overall small number of respiratory dis-
urbances may have limited the ability to discern effects
ssociated with arousal or desaturation. Nonetheless, our
ata also raise the possibility that additional mechanisms,
uch as large changes in intrathoracic pressure and stimu-
ation of baroreflexes, may contribute to the link between
espiratory disturbances and arrhythmias (25).
In interpreting our findings, it is important to distinguish
etween relative and absolute risk. The overall frequency of
rrhythmias in this community-based cohort was very low
hile the frequency of respiratory disturbances was moder-
te. Crude estimates of absolute arrhythmia rate suggest
hat 1 excess arrhythmia may occur per 1,000 h of sleep in
ubjects with a median AHI of 23 events/h. The high and
rowing prevalence of SDB, which influences the effective
azard period in the population, suggests that respiratory
isturbances may contribute to a considerable number of
xcess episodes of PAF or NSVT. In addition, it is possible
hat risk is not evenly distributed in the population and that
he rate of SDB-associated arrhythmias may be even higher
mong patients with impaired cardiac function or with other
isk factors that enhance their vulnerability to physiological
tressors.
The high relative risk may provide insights into prior
tudies demonstrating adverse cardiovascular outcomes in
atients with SDB, including AF. Our results reveal a
ignificant association between the risk of PAF and the
resence of a respiratory disturbance within the pre-defined
azard period. Significant associations between AF and
DB have been previously reported (9,30); specifically, SDB
s a risk factor for incident AF (11) and for recurrence of AF
fter electrical cardioversion (31). Repeated exposures to
ntervals of relatively high risk for PAF, both within a given
ight and over many nights, may result in an increasing
umulative burden of discrete PAF episodes over time. Each
f these paroxysms may increase the propensity for further
nd sustained episodes of AF due to electrical remodeling
ithin the atria (32). Therefore, untreated SDB may serves an ongoing source of AF stimulation, leading ultimately do initiation or recurrence of clinically significant arrhyth-
ia. Correspondingly, it is plausible that treatment of
nderlying SDB may inhibit progression of subclinical PAF
o a more detrimental form of the arrhythmia. A marked
ise in the prevalence of AF is anticipated in coming years,
ith 60% of that increase estimated to be attributable to
besity (33). Our data, which temporally link SDB events
nd the risk of PAF, suggest that unrecognized SDB may be
contributing factor to the projected increase in AF due to
besity.
Our finding of increased risk of NSVT during the hazard
eriod after a respiratory disturbance may provide further
nsight into the observed nocturnal predominance of sudden
ardiac death in SDB patients (14). For patients with
tructural heart disease, the risk of SCD is higher for those
ith NSVT relative to those without it (34,35). Therefore,
ur findings raise the possibility that, in a sufficiently
usceptible population, SDB increases the nocturnal risk of
CD by providing frequent nocturnal exposure to a stimulus
hat increases the likelihood of ventricular arrhythmia. This
ossibility is supported by a recent study of heart failure
atients with implantable cardioverter-defibrillator devices
hat demonstrated that appropriate antitachycardia thera-
ies for ventricular tachycardia or ventricular fibrillation
ere delivered more frequently in those with SDB than in
hose without SDB; this relationship was present only
uring sleeping hours (36). Furthermore, even in the ab-
ence of structural heart disease, SDB has been found to be
ighly prevalent in patients with frequent premature ven-
ricular contractions and/or ventricular tachycardia (37); our
esults are consistent with this observation as well.
tudy strengths and limitations. A strength of the present
tudy was the utilization of the case-crossover design.
ecause subjects served as their own controls, this approach
ssentially eliminated confounding by subject characteristics
hat remained constant during the observation period, a
hallenge in all prior work in this area. In addition, the study
articipants are part of a community-based cohort, rather
han patients with a homogenous cardiovascular profile, and
epresent the full spectrum of SDB severity; both of these
eatures enhance the generalizability of our findings.
A limitation of the current study is the small number of
etected arrhythmias (38), which reduced the ability to
etect potential effect modification by underlying risk fac-
ors, subject characteristics, and sleep-state effects. How-
ver, the case-crossover design allows for analytic efficiency
s well as a minimum of confounding for between-
ndividual comparisons. Detailed information regarding
aytime arrhythmia prevalence and temporal distribution
re not readily available, rendering impractical a direct
omparison between the arrhythmia profiles of our cohort
uring wakefulness and sleep. We limited our assessment of
octurnal arrhythmias to PAF and NSVT; inclusion of
omplex ventricular ectopy as part of the analysis would
ave increased our sample size, perhaps at the expense of
irect clinical impact of the results.
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his study demonstrates that, across the range of SDB, the
isk of clinically important nocturnal arrhythmias is mark-
dly increased shortly after the occurrence of apneas and
ypopneas during sleep. This work provides further evi-
ence that intermittent airflow obstruction may lead to
linically important adverse cardiac effects, and that such
ffects may occur even in persons without severe levels of
DB. Further research is needed to evaluate the ability of
harmacotherapy and/or SDB treatment to modify these
ssociations.
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